Reports for APOTEX INC
Company Name
APOTEX INC
Totals |
||
Shortage reports |
3526 |
|
| Actual shortage: | 229 (6%) | |
| Anticipated shortage: | 3 (0%) | |
| Avoided shortage: | 11 (0%) | |
| Resolved: | 3283 (93%) | |
Discontinuation Reports |
366 |
|
| To be discontinued: | 24 (7%) | |
| Discontinued: | 342 (93%) | |
| Reversed: | 0 (0%) | |
Late reports |
143 (4%) |
|
Overdue reports |
32 (13%) |
|
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| APO-FLUOXETINE | 20MG | CAPSULE | Resolved | 2024-02-23 | 2024-03-01 | 220453 |
| APO-FLUOXETINE | 20MG | CAPSULE | Resolved | 2024-02-26 | 2024-03-01 | 220650 |
| APO-FLUOXETINE | 10MG | CAPSULE | Resolved | 2024-12-11 | 2025-03-14 | 245456 |
| APO-FLUOXETINE | 20MG | CAPSULE | Resolved | 2024-12-11 | 2025-03-14 | 245459 |
| APO-FLUOXETINE | 20MG | CAPSULE | Avoided shortage | 2024-12-11 | 2025-04-10 | 245462 |
| APO-FLUTICASONE HFA | 125MCG | METERED-DOSE AEROSOL | Resolved | 2023-02-23 | 2023-03-02 | 185486 |
| APO-FLUTICASONE HFA | 125MCG | METERED-DOSE AEROSOL | Resolved | 2023-10-27 | 2023-11-06 | 208406 |
| APO-FLUTICASONE HFA | 125MCG | METERED-DOSE AEROSOL | Resolved | 2024-07-12 | 2024-08-09 | 232835 |
| APO-FLUTICASONE HFA | 125MCG | METERED-DOSE AEROSOL | Resolved | 2024-11-14 | 2024-12-20 | 243089 |
| APO-FLUVOXAMINE | 50MG | TABLET | Resolved | 2022-09-01 | 2022-10-07 | 168367 |
| APO-FLUVOXAMINE | 50MG | TABLET | Resolved | 2022-12-23 | 2023-02-17 | 179453 |
| APO-FLUVOXAMINE | 50MG | TABLET | Resolved | 2023-04-06 | 2023-07-27 | 188940 |
| APO-FLUVOXAMINE | 100MG | TABLET | Resolved | 2023-10-20 | 2024-01-19 | 207710 |
| APO-FLUVOXAMINE | 100MG | TABLET | Resolved | 2024-04-05 | 2024-05-17 | 224592 |
| APO-FLUVOXAMINE | 100MG | TABLET | Resolved | 2017-06-28 | 2018-03-04 | 14171 |
| APO-FLUVOXAMINE | 50MG | TABLET | Resolved | 2017-06-28 | 2018-03-04 | 14174 |
| APO-FLUVOXAMINE | 100MG | TABLET | Resolved | 2020-09-22 | 2020-11-02 | 124786 |
| APO-FLUVOXAMINE | 50MG | TABLET | Resolved | 2020-10-14 | 2020-11-02 | 126280 |
| APO-FLUVOXAMINE | 50MG | TABLET | Resolved | 2021-03-05 | 2021-03-29 | 135162 |
| APO-FLUVOXAMINE | 50MG | TABLET | Resolved | 2021-10-15 | 2021-11-29 | 147292 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| APO-TIMOP | 0.5% | SOLUTION | Discontinued | 2019-01-03 | 2019-01-03 | 70894 |
| APO-TIMOP GEL | Discontinued | 2019-01-03 | 2019-01-03 | 71020 | ||
| APO-TIMOP | Discontinued | 2019-01-02 | 2019-01-02 | 70818 | ||
| APO-TOLTERODINE | 1MG | TABLET | Discontinued | 2018-09-08 | 2019-01-17 | 60822 |
| APO-TOLTERODINE | 2MG | TABLET | Discontinued | 2018-09-08 | 2018-11-09 | 60825 |
| APO-TOLTERODINE | 2MG | TABLET | Discontinued | 2018-09-08 | 2019-06-12 | 60828 |
| APO-TRAZODONE TABLETS 100MG | 100MG | TABLET | Discontinued | 2018-09-08 | 2018-09-15 | 60831 |
| APO-TRAZODONE TABLETS 50MG | 50MG | TABLET | Discontinued | 2018-09-08 | 2018-09-15 | 60834 |
| APO-VALACYCLOVIR | 500MG | TABLET | Discontinued | 2018-09-08 | 2018-09-15 | 60840 |
| APO-VALGANCICLOVIR | 450MG | TABLET | Discontinued | 2018-09-08 | 2018-09-15 | 60843 |
| APO-VALPROIC ACID ORAL SOLUTION | 250MG | SOLUTION | Discontinued | 2023-09-26 | 2023-11-02 | 205310 |
| APO-VALSARTAN | Discontinued | 2019-01-03 | 2019-01-03 | 71029 | ||
| APO-VALSARTAN | Discontinued | 2019-01-03 | 2019-01-03 | 71032 | ||
| APO-VALSARTAN | Discontinued | 2019-01-03 | 2019-01-03 | 71035 | ||
| APO-VALSARTAN | Discontinued | 2019-01-03 | 2019-01-03 | 71038 | ||
| APO-VALSARTAN/HCTZ | Discontinued | 2019-01-03 | 2019-01-03 | 71044 | ||
| APO-VALSARTAN/HCTZ | Discontinued | 2019-01-03 | 2019-01-03 | 71048 | ||
| APO-VALSARTAN/HCTZ | Discontinued | 2019-01-03 | 2019-01-03 | 71051 | ||
| APO-VALSARTAN/HCTZ | 12.5MG 160MG | TABLET | Discontinued | 2019-01-03 | 2019-01-03 | 71054 |
| APO-VALSARTAN/HCTZ | Discontinued | 2019-01-03 | 2019-01-03 | 71057 |